Groundbreaking Research Reveals New Role for Weight-Loss Hormone

A recent study conducted by researchers at McMaster University has shed light on the unexpected role of a naturally occurring hormone known for reducing appetite and supporting weight loss. The hormone, called GDF15, has been found to protect the liver from inflammation through a previously unknown signaling pathway.

The study, published in Cell Metabolism on August 10, 2026, discovered that GDF15 can reduce liver inflammation and slow the development of liver scarring even when weight loss does not occur. This finding challenges the long-held view that the hormone’s benefits are primarily tied to its effects on appetite and body weight.

Millions of people worldwide are affected by metabolic dysfunction-associated steatohepatitis (MASH), an advanced form of fatty liver disease that can eventually lead to cirrhosis, liver cancer, and liver failure. New weight loss medications have helped improve outcomes for many patients, but inflammation in the liver can remain even after substantial weight loss.

By identifying a biological pathway that directly regulates this inflammation, the new findings suggest that future therapies could potentially target liver inflammation alongside existing treatments focused on weight and liver fat.